Studies on pristinamycin synergism in Staphylococcus aureus

Area of Science:

• Microbiology
• Molecular Biology
• Pharmacology

Background:

• Pristinamycin is a streptogramin antibiotic effective against Gram-positive bacteria.
• The pristinamycin complex consists of two components: pristinamycin IA (PIA) and pristinamycin IIA (PIIA).
• Understanding the interaction of pristinamycin components with bacterial ribosomes is crucial for explaining its mechanism of action and resistance.

Purpose of the Study:

• To investigate the binding interactions of pristinamycin IA (PIA) and pristinamycin IIA (PIIA) with ribosomes from sensitive and resistant Staphylococcus aureus.
• To determine the effect of PIIA on the affinity of PIA for its ribosomal receptor.
• To explore the correlation between PIA-ribosome affinity and PIA uptake by bacterial cells.

Main Methods:

• Binding experiments utilizing ribosomes isolated from sensitive and resistant Staphylococcus aureus strains.
• Fluorescence polarization assays to quantify the binding of PIA to ribosomes.
• Analysis of synergistic effects between PIA and PIIA on binding affinity and bacterial inhibition.

Main Results:

• A direct correlation was observed between the synergistic action of PIA and PIIA and the enhanced affinity of PIA for its ribosomal receptor.
• PIIA significantly increases the binding affinity of PIA to ribosomes.
• The uptake of PIA by intact Staphylococcus aureus cells appears to be directly proportional to the affinity of PIA for bacterial ribosomes.

Conclusions:

• Pristinamycin IIA (PIIA) enhances the binding of pristinamycin IA (PIA) to Staphylococcus aureus ribosomes, contributing to their synergistic activity.
• The enhanced affinity of PIA for ribosomes in the presence of PIIA likely plays a key role in the overall efficacy of the pristinamycin complex.
• The observed correlation between binding affinity and cellular uptake suggests a conserved mechanism for antibiotic entry, potentially shared with macrolide antibiotics.